Glioblastoma therapy with cytotoxic mesenchymal stromal cells optimized by bioluminescence imaging of tumor and therapeutic cell response.

Glioblastoma therapy with cytotoxic mesenchymal stromal cells optimized by bioluminescence imaging of tumor and therapeutic cell response.

Item
http://www.wikidata.org/entity/Q34243638
Biodistribution, migration and homing of systemically applied mesenchymal stem/stromal cellsGenetically modified mesenchymal stromal cells in cancer therapyMesenchymal stem cells from human fat engineered to secrete BMP4 are nononcogenic, suppress brain cancer, and prolong survivalInfluence of mesenchymal stem cells on metastasis development in mice in vivoImaging of Orthotopic Glioblastoma Xenografts in Mice Using a Clinical CT Scanner: Comparison with Micro-CT and HistologyFibrin matrices enhance the transplant and efficacy of cytotoxic stem cell therapy for post-surgical cancer.Endothelial differentiation of adipose tissue-derived mesenchymal stromal cells in glioma tumors: implications for cell-based therapy.Therapeutic efficacy and fate of bimodal engineered stem cells in malignant brain tumors.CRISPR/Cas9-Mediated Knockin Application in Cell Therapy: A Non-viral Procedure for Bystander Treatment of Glioma in Mice.Preventing inflammation inhibits biopsy-mediated changes in tumor cell behavior.Engineered Mesenchymal Stem Cells as an Anti-Cancer Trojan Horse.Bifidobacterium infantis-mediated HSV-TK/GCV suicide gene therapy induces both extrinsic and intrinsic apoptosis in a rat model of bladder cancer.Complete regression of glioblastoma by mesenchymal stem cells mediated prodrug gene therapy simulating clinical therapeutic scenario.Kinin-B1 Receptor Stimulation Promotes Invasion and is Involved in Cell-Cell Interaction of Co-Cultured Glioblastoma and Mesenchymal Stem Cells.Application of an assay Cascade methodology for a deep preclinical characterization of polymeric nanoparticles as a treatment for gliomas.Neural differentiation of mesenchymal stem cells influences their chemotactic responses to stromal cell-derived factor-1α.Glioblastoma Bystander Cell Therapy: Improvements in Treatment and Insights into the Therapy Mechanisms
P2860

Glioblastoma therapy with cytotoxic mesenchymal stromal cells optimized by bioluminescence imaging of tumor and therapeutic cell response.

Item
http://www.wikidata.org/entity/Q34243638
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Glioblastoma therapy with cyto ...... and therapeutic cell response.
@ast
Glioblastoma therapy with cyto ...... and therapeutic cell response.
@en
Glioblastoma therapy with cyto ...... and therapeutic cell response.
@nl
type
label
Glioblastoma therapy with cyto ...... and therapeutic cell response.
@ast
Glioblastoma therapy with cyto ...... and therapeutic cell response.
@en
Glioblastoma therapy with cyto ...... and therapeutic cell response.
@nl
prefLabel
Glioblastoma therapy with cyto ...... and therapeutic cell response.
@ast
Glioblastoma therapy with cyto ...... and therapeutic cell response.
@en
Glioblastoma therapy with cyto ...... and therapeutic cell response.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Glioblastoma therapy with cyto ...... and therapeutic cell response.
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0035148
P407
P433
P478
P50
P577
P5875
P698
P921
P932